Consent for the use of cookies and other tools

Tools and cookies used on the website collect information about visitors in anonymized form. Your consents enable us to ensure the functioning of all website features, customize certain content specifically for you, and continuously improve the website by analyzing visits.

Types of Cookies

I consent to the website use of tools, including cookies, which ensure full functionality and an appropriate level of security. I understand that without this, the website cannot offer proper functioning, such as website navigation, customization of appearance, and access to specific parts of the website.

I consent to the website use of tools, including cookies, which collect anonymized data about website visitors. I understand that without this, website administrators cannot analyze site traffic and usage patterns to improve the user experience on the website.

Changes were successfully saved

Programme type

Master

Programme feature

Joint

Duration

2

No. of ECTS credit points

120

Partner Institutions

  • Universidad Pompeu Fabra
  • Radboud Universiteit
  • Sapienza Università di Roma

About the programme

The EMAI Programme is a two-year (120 ECTS) Erasmus Mundus Joint Master Degree that provides a comprehensive framework of theory and practice in the field of Artificial Intelligence (AI). The Programme, based in four European research universities, will give the students the foundational knowledge needed to explore both key contextual areas and complex technical applications of AI systems.

The four universities involved are top academic institutions representing world-leading research in Europe: Pompeu Fabra University (UPF) in Barcelona, Sapienza University of Rome in Rome (Italy), Radboud University in Nijmegen (The Netherlands), and University of Ljubljana in Ljubljana (Slovenia). The rest of the consortium is made up of the prestigious University College London (UCL) Centre for Artificial Intelligence, and other AI research centres worldwide, as well as 12 industrial partners, including multinational companies as well as small and medium-sized enterprises.